<DOC>
	<DOCNO>NCT01651078</DOCNO>
	<brief_summary>The need new technology device field neurosurgery well establish . In April 2013 , FDA clear NeuroBlate™ System , minimally invasive robotic laser thermotherapy tool . It employ pulsed surgical laser deliver target energy abnormal brain tissue cause tumor lesion . This post-marketing , multi-center study include patient metastatic tumor fail stereotactic radiosurgery already schedule NeuroBlate procedure . The study collect clinical outcome , Quality Life ( QoL ) , feasible , healthcare utilization data publication .</brief_summary>
	<brief_title>Laser Ablation After Stereotactic Radiosurgery</brief_title>
	<detailed_description />
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<criteria>Key 1 . Patient sign receive copy Informed Consent Form 2 . Patient may 3 target supratentorial metastatic lesion previously treat stereotactic radiosurgery , radiological evidence progression , pseudoprogression radionecrosis . Subject may additional non target lesion present long expect ( Investigator 's judgment ) contribute symptomatology course study confound interpretation radiological clinical measure . 3 . Karnofsky Performance Status ( KPS ) ≥ 60 . Key 1 . Females pregnant , breast feeding , plan become pregnant 6 month follow index procedure . 2 . Leptomeningeal metastasis . 3 . Uncontrolled infectious process . 4 . Uncontrolled hypertension ( systolic &gt; 180 mm Hg ) , angina pectoris , cardiac dysrhythmia , recent ( within 6 week ) history intracranial hemorrhage . 5 . Serious infection , immunosuppression concurrent medical condition ( chronic acute nature ) may prevent safe participation ability meet followup requirement . 6 . Abnormal absolute neutrophil count ( ANC &lt; 1000/mm ) , platelet ( &lt; 100,000/mm ) administration antiplatelet agent ( aspirin , plavix etc ) anticoagulation within 7 day prior treatment . 7 . Inadequate bone marrow , liver renal function ( e.g. , total bilirubin &gt; 1.5 x ULN ; AST , ALT &gt; 2.5 x ULN ; alkaline phosphatase &gt; 2.5 x ULN ; serum creatinine &gt; 1.5 x ULN ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Metastatic Brain Tumors</keyword>
	<keyword>Progression</keyword>
	<keyword>Radiation Necrosis</keyword>
	<keyword>Quality Life</keyword>
</DOC>